-
5 Ways You can Achieve High Returns with Low Risk
Tuesday, February 1, 2011 - 2:23am | 1045You are led to believe that you need to take risk to achieve high returns. But that couldn't be further from the truth.Here are a few low risk investment ideas worth considering. 1. Focus on an existing businessLook at businesses with long history of operations that you can analyze. This is much...
-
Perrigo Company (PRGO) - Bull of the Day
Tuesday, February 1, 2011 - 1:00am | 166Perrigo Company (PRGO) reported first quarter fiscal 2011 EPS of $0.87, well above the Zacks Consensus Estimate of $0.77. We believe that Perrigo's strong position in the brand OTC pharmaceutical market and growing generics and API businesses will help it deliver solid top- and bottom-line growth...
-
King Pharmaceuticals Announces Offer to Purchase Notes (KG)
Monday, January 31, 2011 - 5:09pm | 492King Pharmaceuticals, Inc. (NYSE: KG) announced today that it has commenced a tender offer (the "Convertible Notes Tender Offer") to repurchase, at the option of each holder, any and all of its outstanding 1 1/4% Convertible Senior Notes Due 2026 (the "Convertible Notes"). The Company is offering...
-
Earnings Scorecard: Stryker - Analyst Blog
Monday, January 31, 2011 - 4:01pm | 1234Orthopedic devices giant Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted (excluding one-time charges) earnings per share of 93 cents, above the Zacks Consensus Estimate of 90 cents. Highlights from the Quarter Profit (as reported) for...
-
Earnings Scorecard: Stryker - Analyst Blog
Monday, January 31, 2011 - 3:19pm | 1234Orthopedic devices giant Stryker Corporation (SYK) reported better-than-expected fourth-quarter fiscal 2010 results with adjusted (excluding one-time charges) earnings per share of 93 cents, above the Zacks Consensus Estimate of 90 cents. Highlights from the Quarter Profit (as reported) for...
-
Earnings Scorecard: Forest Labs - Analyst Blog
Monday, January 31, 2011 - 2:03pm | 831Following the release of third quarter fiscal 2011 results on January 18, 2010, almost all the analysts covering Forest Laboratories (FRX) have made upward revisions to their earnings estimates for 2011 and 2012. The upward revision in estimates is mainly in response to the company's revised...
-
Earnings Preview: Alkermes - Analyst Blog
Monday, January 31, 2011 - 2:03pm | 879Alkermes Inc.(ALKS) is all set to announce its third quarter fiscal 2011 results on February 3, 2011 after the close of market. The Zacks Consensus Estimate for the third quarter of fiscal 2011 hints at a loss of $0.15 per share, as against a loss of $0.03 incurred in the year ago quarter....
-
Actelion, Glaxo Halt Study - Analyst Blog
Monday, January 31, 2011 - 1:31pm | 382Recently, Actelion Ltd (ALIOF) and partner GlaxoSmithKline (GSK) halted the development of almorexant, which was undergoing late-stage development to treat patients suffering from sleeping disorders or insomnia. The Switzerland based Actelion inked a global (excluding Japan) deal with Glaxo to...
-
Earnings Preview: Alkermes - Analyst Blog
Monday, January 31, 2011 - 1:30pm | 879Alkermes Inc.(ALKS) is all set to announce its third quarter fiscal 2011 results on February 3, 2011 after the close of market. The Zacks Consensus Estimate for the third quarter of fiscal 2011 hints at a loss of $0.15 per share, as against a loss of $0.03 incurred in the year ago quarter....
-
Earnings Scorecard: Forest Labs - Analyst Blog
Monday, January 31, 2011 - 1:15pm | 831Following the release of third quarter fiscal 2011 results on January 18, 2010, almost all the analysts covering Forest Laboratories (FRX) have made upward revisions to their earnings estimates for 2011 and 2012. The upward revision in estimates is mainly in response to the company's revised...
-
Teva Expands in Latin America - Analyst Blog
Monday, January 31, 2011 - 1:01pm | 359In order to strengthen its presence in Latin America, Teva Pharmaceutical Industries Ltd. (TEVA) recently announced its intention to acquire Peruvian company Corporación Infarmasa. With this acquisition, Teva will gain access to Infarmasa's portfolio of more than 600 products, of which over 500...
-
Actelion, Glaxo Halt Study - Analyst Blog
Monday, January 31, 2011 - 1:00pm | 382Recently, Actelion Ltd (ALIOF) and partner GlaxoSmithKline (GSK) halted the development of almorexant, which was undergoing late-stage development to treat patients suffering from sleeping disorders or insomnia. The Switzerland based Actelion inked a global (excluding Japan) deal with Glaxo to...
-
Teva Expands in Latin America - Analyst Blog
Monday, January 31, 2011 - 12:45pm | 359In order to strengthen its presence in Latin America, Teva Pharmaceutical Industries Ltd. (TEVA) recently announced its intention to acquire Peruvian company Corporación Infarmasa. With this acquisition, Teva will gain access to Infarmasa's portfolio of more than 600 products, of which over 500...
-
Top Narrow Based Indexes For January 31 (DEPO, URZ, MEE)
Monday, January 31, 2011 - 12:21pm | 211By 11:00 am, the Dow Jones Industrial Average was up 23.92 points, or 0.20%, to 11,847.62, while the broader Standard & Poor's 500 index had gained 4.94 points, or 0.39%. The NASDAQ composite index fell 0.59 point, or 0.02%. Some of the narrow based indexes that are supporting the markets are...
-
NASDAQ Stocks Hitting 52-Week Highs (CLDA, DEPO, CPSI, NPSP)
Monday, January 31, 2011 - 11:41am | 170Clinical Data Inc (NASDAQ: CLDA) shares gained 3.12% to create a new 52-week high of $28.22. CLDA shares have advanced 78.01% over the past 52 weeks, while the S&P 500 index has gained 18.85% in the same period. Depomed Inc (NASDAQ: DEPO) shares surged 30.45% to create a new 52-week high of $8....